- ►annals.org [PDF] PL Hebert, JE Sisk, JJ Wang, L Tuzzio, JM … - Annals of Internal Medicine, 2008 - Am Coll Physicians Background: Randomized, controlled trials have shown that nurse- led disease
management for patients with heart failure can reduce hospitalizations. Less is
known about the cost-effectiveness of these interventions. Cited by 2 - Related articles - All 6 versions
- ►critcaremed.com PS Chan, G Soto, PG Jones, BK Nallamothu, … - Circulation, 2009 - Am Heart Assoc Methods and Results— We evaluated 12-month cost utilization data from 1516
heart failure outpatients enrolled in the Quality-of-Life Substudy of the
Eplerenone Post–Myocardial Infarction Heart Failure Efficacy and Survival ... Cited by 3 - Related articles - All 6 versions
JA Ezekowitz, P Kaul, JA Bakal, PW … - Journal of the American College of Cardiology, 2009 - Elsevier In-hospital HF is common after MI and is associated with poor short-term
prognosis. Limited data exist concerning the long-term incidence or prognosis of
HF after MI, particularly in the era of coronary revascularization. Cited by 5 - Related articles - All 13 versions
[CITATION] Cost-Effectiveness of Nurse-Led Disease Management for Heart Failure in an Ethnically …
- ►oxfordjournals.org WC Chang, P Kaul, Y Fu, CM Westerhout, CB … - European heart journal, 2006 - Eur Soc Cardiology Methods and results In 6066 STEMI patients enrolled in the Assessment of the
Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trial with complete
electrocardiographic data, we assessed the probability of 30-day mortality ... Cited by 11 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org M Kosiborod, GE Soto, PG Jones, HM … - Circulation, 2007 - Am Heart Assoc Methods and Results— We evaluated 1358 patients with heart failure after an
acute myocardial infarction in the Eplerenone's Neurohormonal Efficacy and
Survival Study, a multicenter randomized trial that included serial KCCQ ... Cited by 16 - Related articles - All 6 versions
